These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 5863724)

  • 21. Antituberculous drugs in patients with chronic liver disease.
    Kimmoun E; Samuel D
    J Gastroenterol Hepatol; 2002 Dec; 17 Suppl 3():S408-12. PubMed ID: 12472972
    [No Abstract]   [Full Text] [Related]  

  • 22. Safety of rifampin and pyrazinamide for the treatment of latent tuberculosis infection.
    Stout JE
    Expert Opin Drug Saf; 2004 May; 3(3):187-98. PubMed ID: 15155147
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tuberculous liver abscess.
    Kanagaraj A; Marthandam LR; Sriramakrishnan V; Rajesh A; Meenakumari P
    J Assoc Physicians India; 2008 Aug; 56():647-8. PubMed ID: 19051717
    [No Abstract]   [Full Text] [Related]  

  • 24. Chemotherapy of tuberculosis for the 1980's.
    Dutt AK; Stead WW
    Prim Care; 1980 Sep; 7(3):513-27. PubMed ID: 7003628
    [No Abstract]   [Full Text] [Related]  

  • 25. [Use of lymphotropic therapy in the multimodality treatment of patients with pulmonary tuberculosis and comorbidity].
    Ubaĭdullaev AM; Belotserkovets VG
    Probl Tuberk Bolezn Legk; 2004; (12):50-2. PubMed ID: 15719669
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rifampicin/pyrazinamide therapy should not be used for latent tuberculosis infection.
    Garca-Doval I
    J Am Acad Dermatol; 2004 May; 50(5):801; author reply 801-2. PubMed ID: 15097974
    [No Abstract]   [Full Text] [Related]  

  • 27. [National investigation of the therapeutic use of rifamycin SV with the help of the Argentine medical profession].
    Gindin LR; Carozzi MR
    Prensa Med Argent; 1965 Jun; 52(22):1391-8. PubMed ID: 5845354
    [No Abstract]   [Full Text] [Related]  

  • 28. [Hepatotoxicity of the tuberculostatic combination INH+RMP+EMB in relation to drug metabolism in the liver].
    Musch E; Eichelbaum M; Wang JK; von Sassen W; Ochs HR; Castro-Parra M; Dengler HJ
    Med Welt; 1982 Jun; 33(25):911-4. PubMed ID: 7109939
    [No Abstract]   [Full Text] [Related]  

  • 29. [Acute renal insufficiency and interstitial nephritis caused by rifampicin. A comment on this subject].
    Santacruz PL; Agüero F; León ME; Córdoba Z
    Nefrologia; 2001; 21(3):323. PubMed ID: 11471316
    [No Abstract]   [Full Text] [Related]  

  • 30. [Side effects of antitubercular drugs leading to discontinuation of drug therapy].
    Bergan S; Laake K; Bjartveit K
    Tidsskr Nor Laegeforen; 1980 Feb; 100(5):279-82. PubMed ID: 7385151
    [No Abstract]   [Full Text] [Related]  

  • 31. [Reasons for drug-resistant tuberculosis emergence].
    Tu DH
    Zhonghua Jie He He Hu Xi Za Zhi; 2007 Jun; 30(6):403-5. PubMed ID: 17673006
    [No Abstract]   [Full Text] [Related]  

  • 32. [Case of fatal liver failure due to anti-tuberculous therapy].
    Harada Y; Kawakami K; Koyama K; Yamaryo T; Kimura Y
    Kekkaku; 2007 Sep; 82(9):705-9. PubMed ID: 17969987
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Four cases of similar Hexheimer's reaction during the initial chemotherapy for tuberculosis bacillus].
    Lu H; Wu H; Liang G
    Zhonghua Jie He He Hu Xi Za Zhi; 1995 Dec; 18(6):348-50, 382-3. PubMed ID: 8762493
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Side effects of various combinations of rifampin and isoniazid with ethambutol or streptomycin and pyrazinamide in short-term chemotherapy of newly-detected pulmonary tuberculosis].
    Zierski M; Bek E
    Pneumonol Pol; 1980 Jul; 48(7):469-79. PubMed ID: 7433146
    [No Abstract]   [Full Text] [Related]  

  • 35. Optic neuritis and bitemporal hemianopsia associated with isoniazid treatment in end-stage renal failure.
    Kocabay G; Erelel M; Tutkun IT; Ecder T
    Int J Tuberc Lung Dis; 2006 Dec; 10(12):1418-9. PubMed ID: 17171829
    [No Abstract]   [Full Text] [Related]  

  • 36. A current approach to the management of tuberculosis infection.
    Jasmer RM; Small PM
    Curr Clin Top Infect Dis; 2000; 20():209-31. PubMed ID: 10943526
    [No Abstract]   [Full Text] [Related]  

  • 37. [Tuberculosis of the middle ear: a rare extrapulmonary manifestation].
    Schütte W; Berghaus A; Schütte A
    Dtsch Med Wochenschr; 1996 Dec; 121(49):1551. PubMed ID: 8998926
    [No Abstract]   [Full Text] [Related]  

  • 38. Rifamycin treatment of tuberculosis in a patient receiving atenolol: less interaction with rifabutin than with rifampin.
    Goldberg SV; Hanson D; Peloquin CA
    Clin Infect Dis; 2003 Aug; 37(4):607-8. PubMed ID: 12905149
    [No Abstract]   [Full Text] [Related]  

  • 39. [Surface activity of watery solutions of Rifamycin SV].
    Florstedt H; Bornschein M; Voigt R
    Pharmazie; 1971 Dec; 26(12):779-80. PubMed ID: 5141267
    [No Abstract]   [Full Text] [Related]  

  • 40. [Rifamycin: progress in development of antiviral agents].
    Beker I
    Harefuah; 1971 Mar; 80(6):336-8. PubMed ID: 5140806
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.